Home > Quotes > MYL
MYL

Mylan N.V. Ordinary Shares Quote & Summary Data

$42.6
*  
1.88
4.23%
Get MYL Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Mylan N.V. Ordinary Shares Intraday Chart




News for MYL

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 43.88 $ 75.26
Low $ 42.455 $ 37.59

The current last sale of $42.60 is 13.33% Higher thanthe 52 week low.

P/E Ratio

ETFs with MYL as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.14% SPDR S&P Pharmaceuticals ETF (XPH) -11.31 (-20.76%)
4.08% iShares Nasdaq Biotechnology Index Fund (IBB) -56.45 (-16.90%)
3.81% iShares U.S. Pharmaceutical ETF (IHE) -19.73 (-12.06%)
0% Proshares UltraPro Nasdaq Biotechnology (UBIO) -28.38 (-50.29%)
0% Direxion iBillionaire Index ETF (IBLN) -0.15 (-0.61%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Mylan N.V., along with its subsidiaries (collectively, the "Company," "Mylan," "our" or "we"), is a leading global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan is committed to setting new standards in healthcare by creating better health for a better world, and our mission is to provide the world's 7 billion people access to high quality medicine. To do so, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. Mylan offers one of the industry's broadest product portfolios, including more than 1,400 marketed products, to customers in approximately 165 countries and territories.  ... More ...  

Risk Grade

Where does MYL fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?